Related references
Note: Only part of the references are listed.Medicinal plant Combreturn leprosum mart ameliorates motor, biochemical and molecular alterations in a Parkinson's disease model induced by MPTP
Livia S. Moraes et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13C NMR study
Puneet Bagga et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways
Cheng Xiao et al.
NEURON (2016)
Behavioural, biochemical and molecular changes induced by chronic crack-cocaine inhalation in mice: The role of dopaminergic and endocannabinoid systems in the prefrontal cortex
Lorena B. Areal et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Chronic MPTP treatment produces hyperactivity in male mice which is not alleviated by concurrent trehalose treatment
Sherry A. Ferguson et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Activity of Monoamine Oxidase in the Nigrostriatal System at Presymptomatic and Early Symptomatic Stages of Parkinsonism in Mice
G. R. Khakimova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output
Shengyuan Ding et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Absence of Glia Maturation Factor Protects Dopaminergic Neurons and Improves Motor Behavior in Mouse Model of Parkinsonism
Mohammad Moshahid Khan et al.
NEUROCHEMICAL RESEARCH (2015)
INTERVENTION WITH EXERCISE RESTORES MOTOR DEFICITS BUT NOT NIGROSTRIATAL LOSS IN A PROGRESSIVE MPTP MOUSE MODEL OF PARKINSON'S DISEASE
M. D. Sconce et al.
NEUROSCIENCE (2015)
Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice
Asokan Prema et al.
NEUROSCIENCE LETTERS (2015)
In the right place at the right time: visualizing and understanding mRNA localization
Adina R. Buxbaum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice
Yoko Hagino et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Multiphasic Modulation of Cholinergic Interneurons by Nigrostriatal Afferents
Christoph Straub et al.
JOURNAL OF NEUROSCIENCE (2014)
NOBILETIN TREATMENT IMPROVES MOTOR AND COGNITIVE DEFICITS SEEN IN MPTP-INDUCED PARKINSON MODEL MICE
Y. Yabuki et al.
NEUROSCIENCE (2014)
Timing in reward and decision processes
Maria A. Bermudez et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity
Terence Y. C. Pang et al.
NEUROPHARMACOLOGY (2013)
Reduced calcium/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice
Shigeki Moriguchi et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease
Natalie R. S. Goldberg et al.
NEUROBIOLOGY OF DISEASE (2012)
The Local Transcriptome in the Synaptic Neuropil Revealed by Deep Sequencing and High-Resolution Imaging
Ivan J. Cajigas et al.
NEURON (2012)
Roles of the M1 Muscarinic Acetylcholine Receptor Subtype in the Regulation of Basal Ganglia Function and Implications for the Treatment of Parkinson's Disease
Zixiu Xiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
ENRICHED ENVIRONMENT PROMOTES SIMILAR NEURONAL AND BEHAVIORAL RECOVERY IN A YOUNG AND AGED MOUSE MODEL OF PARKINSON'S DISEASE
N. R. S. Goldberg et al.
NEUROSCIENCE (2011)
Prevention and treatment of drug addiction by environmental enrichment
Marcello Solinas et al.
PROGRESS IN NEUROBIOLOGY (2010)
Parkinson's disease: The syndrome, the pathogenesis and pathophysiology
Anna L. Bartels et al.
CORTEX (2009)
History of falls in Parkinson disease is associated with reduced cholinergic activity
N. I. Bohnen et al.
NEUROLOGY (2009)
The neuropathological basis for depression in Parkinson's disease
Pasquale G. Frisina et al.
PARKINSONISM & RELATED DISORDERS (2009)
Enrich the environment to empower the brain
Alessandro Sale et al.
TRENDS IN NEUROSCIENCES (2009)
Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
Francesca Cicchetti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Genetic factors involved in the pathogenesis of Parkinson's disease
Frank J. S. Lee et al.
BRAIN RESEARCH REVIEWS (2008)
Pharmacotherapy for Parkinson's disease
Jack J. Chen et al.
PHARMACOTHERAPY (2007)
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Angela B. Reksidler et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
A hospital-based study:: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy
Gulcin Benbir et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2006)
Novel pharmacological targets for the treatment of Parkinson's disease
Anthony H. V. Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Enriched environment improves motor function in intact and unilateral dopamine-depleted rats
N. M. Jadavji et al.
NEUROSCIENCE (2006)
Enriched environments, experience-dependent plasticity and disorders of the nervous system
Jess Nithianantharajah et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Environmental enrichment in adulthood eliminates neuronal death in experimental Parkinsonism
CJ Faherty et al.
MOLECULAR BRAIN RESEARCH (2005)
The MPTP model of Parkinson's disease
RJ Smeyne et al.
MOLECULAR BRAIN RESEARCH (2005)
Behavioural and neurochemical effects of phosphatidylserine in MPTP lesion of the substantia nigra of rats
JC Perry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Choline transporter 1 maintains cholinergic function in choline acetyltransferase haploinsufficiency
EP Brandon et al.
JOURNAL OF NEUROSCIENCE (2004)
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function
M Lundblad et al.
NEUROBIOLOGY OF DISEASE (2004)
Roles of neurotransmitter in synapse formation: Development of neuromuscular junctions lacking choline acetyltransferase
T Misgeld et al.
NEURON (2002)
Levodopa prolongs life expectancy and is non-toxic to substantia nigra
AH Rajput
PARKINSONISM & RELATED DISORDERS (2001)
Chemical neuroanatomy of the basal ganglia - normal and in Parkinson's disease
O Hornykiewicz
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Early Parkinson's disease - What is the best approach to treatment
AH Hristova et al.
DRUGS & AGING (2000)
Share Paper
